Although recent studies of anti-IL-5 therapies have led to a reduction in exacerbations and improvement of several asthma-control measures in a subpopulation of patients displaying severe eosinophilic asthma, there are other approaches for regulating eosinophils. This evidence concerns the gene IL5 and asthma.